Discovery PET/CT 600 debuted at the RSNA meeting, taking a midtier position in GE Healthcare’s family of hybrid devices.
Discovery PET/CT 600 debuted at the RSNA meeting, taking a midtier position in GE Healthcare’s family of hybrid devices. Discovery PET/CT 600 uses an infrared tracking camera and reflective marker to measure a patient’s respiratory pattern and range of motion that can complicate imaging and lead to problems in evaluating patients for radiation therapy. The real-time position-management technology, developed by Varian Medical Systems, was integrated into the GE device through a partnership between the two firms. Synchronizing the scan with respiration requires substantial processing power, according to GE. The company met the challenge through a collaboration with IBM, which provided its BladeCenter server technology for use in the PET/CT.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.